Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David M. Mott currently holds 3,302,918 shares of Epizyme, Inc. (EPZM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David M. Mott has been a net buyer of EPZM stock. They have purchased $394.4M and sold $142.9M worth of shares.
David M. Mott's most recent insider trade was on Feb 20, 2026, when they purchased 333,333 shares at $5.84 per share.
David M. Mott serves as Executive at Epizyme, Inc. (EPZM). They have executed 320 insider transactions totaling $537.3M over their tenure at the company.
David M. Mott holds the position of Executive at Epizyme, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
David M. Mott has shown a buying trading pattern, with $394.4M in total purchases and $142.9M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by David M. Mott was on Sep 23, 2021, when they sold $2.0M worth of NVAX shares. This transaction involved 7,744 shares at $253.46 per share.
David M. Mott currently owns 3,302,918 shares of Epizyme, Inc. (EPZM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David M. Mott's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David M. Mott has 320 Form 4 filings on record as an insider at Epizyme, Inc..
Set alerts for David M. Mott and 40,000+ other insiders.